Multibagger Stock Under Rs 25: Microcap Company Expands Land Area in Gujarat, Aiming for Rs 100 Crore Revenue and 10 per cent PAT Margin!
The company’s shares have delivered multibagger returns of over 400 per cent to its shareholders in just 3 years.
This micro-cap company is engaged in trading, manufacturing, and marketing research-based Ayurvedic medicines. The company has announced the acquisition of 27,451 square feet of additional land adjacent to its Vapi, Gujarat facility. This expansion will facilitate the establishment of new manufacturing and filling lines to address the increasing export and local demand for its products and will also integrate plastic blow molding and injection capabilities. The new facility is expected to boost production capacity, support a revenue target of approximately Rs 100 crore over the next 2-3 years with a PAT margin of 10 per cent, and offer a comprehensive solution for client needs.
Today shares of Veer Healthcare Ltd closed at around Rs 23.99 per share. The company’s current market capitalization stands at Rs 47.98 crore. Additionally, the shares have delivered a multibagger return of over 290 per cent in the past 2 years.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
As per the Quarterly Results, in Q4 FY24, Veer Healthcare Ltd recorded a revenue of Rs 3.37 crore representing a de-growth of 9.65 per cent YoY from Rs 3.73 crore. The operating profit for Q4 FY24 stood at Rs 0.17 crore along with an operating profit margin of 5.04 per cent. The net loss for Q4 FY24 stood at Rs 0.55 crore compared to a profit of Rs 1.04 crore last year same quarter. Looking at the annual performance, the company generated a revenue of Rs 13.22 crore in FY24. The operating profit for FY24 was Rs 0.61 crore with a net profit of Rs 0.41 crore compared to a net profit of Rs 1.58 crore in FY23.
Investors must keep this micro-cap company on their radar.
Disclaimer: The article is for informational purposes only and not investment advice.